Highlights from this week's Healthcare Transparency News, Studies, and Articles:
Angry Over Drug Prices, More States Push Bills for Pharma to Disclose Costs
[By: Ed Silverman, The Wall Street Journal]
“Should drug makers be required to disclose their costs to justify rising prices? … This is what a growing number of state legislatures are considering.”
More On California’s Pharmaceutical Cost Transparency Act of 2015 from:
- InsuranceNewsNet.com
- LA Times Editorial
- LA Times Readers React
Health Care Cost Should Be Clear In Advance
[By: , MD, Hartford Courant]
“…a series of bipartisan bills making their way through the General Assembly may improve things for those of us living in Connecticut.”
A Big Step Forward for Health Care Transparency in New Mexico
[By:
“NMID recently asked columnists who wrote for our January legislative guide to summarize how, in their opinion, transparency and openness fared during the recently-ended 60-day session in Santa Fe. “
Can Transparency Tools Further the ACA’s Goals of Reducing Costs?
[By: ]
“Research shows that health care transparency tools can be an effective way to help consumers better understand their care and further the ACA’s goal of reducing costs. ”
Have You SEEN Your Options? Focusing Consumerism on Safe, Effective, Economical, Necessary Choices
[By: Wendy Lynch, The Institute for HealthCare Consumerism]
“Despite a significant transition toward high-deductible plans, broader availability of price and quality information, and efforts by many large employers to provide decision tools, fully-informed, in-control consumers are the exception.”
N.C. lawmakers move to inject transparency into drug pricing
[By: Jason deBruyn, Triangle Business Journal]
“The proposal – House Bill 839 – would require pharmaceutical manufacturers to publicly report cost and utilization information.”
Contact us with your news story at news@newchoicehealth.com
